Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a toxin, named after the plant genus Plumbago from which it was first isolated in 1968 (1). Since its discovery there have been a wide variety of publications describing its effects on fertility, hyperlipedaemia (high cholesterol) and its use as an anti-bacterial. More recently, there have been multiple efforts to synthesise derivatives and analogues of plumbagin in order to increase its potential as an anti-cancer agent.
Resistance of tumour cells to apoptosis is a major obstacle to be overcome when treating cancerous malignancies; however plumbagin has been shown to induce apoptosis in several cancer cell lines, including those of the breast, ...